Gene content    
MSH2 ( by HUGO)
MutS Homolog
Tumor suppressor gene
MutS Homolog 2
COCA1
hMSH2
FCC1
HNPCC1
MutS (E. Coli) Homolog 2 (Colon Cancer
Nonpolyposis Type 1)
MutS Homolog 2
Colon Cancer
Nonpolyposis Type 1 (E. Coli)
HNPCC
LCFS2
DNA Mismatch Repair Protein Msh2
MutS Homolog 2
Colon Cancer
Nonpolyposis Type 1
MutS Protein Homolog 2
NCBI: 2p21    Ensembl: 2p21
MSH2_HUMANSize: 934 amino acidsMass: 104743 Da

  • Subunit: Heterodimer consisting of MSH2-MSH6 (MutS alpha) or MSH2-MSH3 (MutS beta). Both heterodimer form a ternary complex with MutL alpha (MLH1-PMS1). Interacts with EXO1. Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ATR. Interacts with SLX4/BTBD12; this interaction is direct and links MutS beta to SLX4, a subunit of different structure-specific endonucleases. Interacts with SMARCAD1 Sequence caution: Sequence=AAC27930.1; Type=Frameshift; Positions=417; Note=The frameshift is caused by a single nucleotide deletion which is found in a HNPCC kindred; Selected PDB 3D structures from [IMAGE] and Proteopedia [IMAGE] for MSH2 (see all 9): 2O8B (3D) [IMAGE] 2O8C (3D) [IMAGE] 2O8D (3D) [IMAGE] 2O8E (3D) [IMAGE] 2O8F (3D) [IMAGE] 3THW (3D) [IMAGE]
  • Tissue specificity: Ubiquitously expressed [IMAGE] Pathway & Disease-focused RT2 Profiler PCR Arrays including MSH2 (see all 8): DNA Damage Signaling Pathway in human mouse rat Liver Cancer in human mouse rat Cell Cycle in human mouse rat Telomeres & Telomerase in human mous
  • Function:
    UniProtKB/Swiss-Prot Summary: MSH2_HUMAN, P43246 Function: Component of the post-replicative DNA mismatch repair system (MMR). Forms two different heterodimers: MutS alpha (MSH2-MSH6 heterodimer) and MutS beta (MSH2-MSH3 heterodimer) which binds to DNA mismatches thereby initiating DNA repair. When bound, heterodimers bend the DNA helix and shields approximately 20 base pairs. MutS alpha recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. MutS beta recognizes larger insertion-deletion loops up to 13 nucleotides long. After mismatch binding, MutS alpha or beta forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair. In melanocytes may modulate both UV-B-induced cell cycle regulation and apoptosis
  • Similarity:
    Belongs to the DNA mismatch repair MutS family [IMAGE]
  • Protein Domain/Family    
    Source ID Domain Name Type
    InterProIPR000432DNA_mismatch_repair_MutS_CDNA mismatch repair protein MutS, C-terminalDomain
    IPR007695DNA_mismatch_repair_MutS-lik_NDNA mismatch repair protein MutS, N-terminalDomain
    IPR007696DNA_mismatch_repair_MutS_coreMutS IIIDomain
    IPR007860DNA_mmatch_repair_MutS_con_domMutS IIDomain
    IPR007861DNA_mismatch_repair_MutS_clampMutS IVDomain
    IPR011184DNA_mismatch_repair_MSH2DNA mismatch repair protein, eukaryotic MSH2Family
    BlocksIPB007696MutS IIIMutS III

    Gene Ontology    
    Type Term Evidence Source Pub
    Biological Process ATP catabolic process IDA GOA 16403449
    DNA repair IDA GOA 8942985
    maintenance of DNA repeat elements IMP GOA 16388310
    mismatch repair IDA GOA 11555625
    negative regulation of DNA recombination IDA GOA 17715146
    positive regulation of helicase activity IDA GOA 17715146
    postreplication repair IDA GOA 7923193
    Cellular Component membrane IDA GOA 19946888
    MutSbeta complex IDA GOA 8942985
    Molecular Function contributes_to ADP binding IDA GOA 15105434
    contributes_to ATP binding IDA GOA 15105434
    contributes_to ATPase activity IDA GOA 16403449
    contributes_to dinucleotide insertion or deletion binding IDA GOA 8942985
    contributes_to dinucleotide repeat insertion binding IDA GOA 8942985
    contributes_to double-stranded DNA binding IDA GOA 11809883
    contributes_to four-way junction DNA binding IDA GOA 12034830
    contributes_to guanine/thymine mispair binding IDA GOA 11809883
    contributes_to magnesium ion binding IDA GOA 16403449
    contributes_to mismatched DNA binding IDA GOA 11756455
    contributes_to MutLalpha complex binding IDA GOA 16403449
    contributes_to oxidized purine DNA binding IDA GOA 11756455
    contributes_to protein binding IPI GOA 16403449
    contributes_to single guanine insertion binding IDA GOA 8942985
    contributes_to single thymine insertion binding IDA GOA 8942985
    contributes_to single-stranded DNA binding IDA GOA 11809883
    DNA binding IDA GOA 7923193
    enzyme binding IPI GOA 10856833
    guanine/thymine mispair binding IMP GOA 16713580
    protein binding IPI GOA 10856833
    protein C-terminus binding IPI GOA 14706347
    protein homodimerization activity IDA GOA 8942985
    protein kinase binding IPI GOA 14657349

    Disorder & Mutation    
    Source Disease
    SWISS-PROTMuir-Torre syndrome (MRTES) [MIM:158320]: Rare autosomal dominant disorder characterized by sebaceous neoplasms and visceral malignancy. Note=The disease is caused by mutations affecting the gene represented in this entry
    SWISS-PROTEndometrial cancer (ENDMC) [MIM:608089]: A malignancy of endometrium, the mucous lining of the uterus. Most endometrial cancers are adenocarcinomas, cancers that begin in cells that make and release mucus and other fluids. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry
    SWISS-PROTHereditary non-polyposis colorectal cancer 1 (HNPCC1) [MIM:120435]: An autosomal dominant disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early-onset colorectal carcinoma (CRC) and extra-colonic tumors of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Clinically, HNPCC is often divided into two subgroups. Type I is characterized by hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II is characterized by increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. The term 'suspected HNPCC' or 'incomplete HNPCC' can be used to describe families who do not or only partially fulfill the Amsterdam criteria, but in whom a genetic basis for colon cancer is strongly suspected. Note=The disease is caused by mutations affecting the gene represented in this entry

    MSH2 cross reference    
    PubMed OMIM Entrez Gene NCKU SNP Nucleotide UniProt Genome Data Viewer HomoloGene